Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 15 results for "olopatadine"

PTAB Life Sciences Report -- December 2016 #2

About the PTAB Life Sciences Report: Each month (or more frequently) we will report on developments at the PTAB involving life sciences patents. Apotex Inc. and Apotex Corp. v. Alcon Research, Ltd. PTAB Petition: IPR2016-01640; filed August 18, ... JD Supra, 1 month ago

1 images for "olopatadine"

PharmaCompass, 3 months ago

A serious issue gets serious attention

SPECIAL SECTION: PATIENT COMPLIANCE Help — lots of it — could be en route via drug delivery devices. By Karl Csaky, MD O cular drug delivery research has generated significant buzz for several reasons: 1.  The eye is a unique, ...
 Ophthalmology Management1 month ago

Argentum and Alcon Settle Patent Dispute Over PAZEO®

NEW YORK, Nov. 30, 2016 /PRNewswire/ -- Argentum Pharmaceuticals LLC, a generic pharmaceutical company,announced today that it has reached a settlement with Alcon Research, Ltd., related to Argentum's generic version of PAZEO® (0.7% olopatadine ...
 TickerTech.com1 month ago

FDA releases 67 new and revised bioequivalence guidelines for generics

Posted 18/11/2016 As part of its ongoing efforts to provide product specific guidance for generics makers the US Food and Drug Administration (FDA) has again released a whole host of new bioequivalence documents. The agency announced on 1 October ...
 GaBi Online2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less